Viewing Study NCT03768505

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 3:28 AM

Ignite Modification Date: 2025-12-26 @ 2:08 AM

Study NCT ID: NCT03768505

Status: TERMINATED

Last Update Posted: 2024-12-31

First Post: 2018-12-04

Is NOT Gene Therapy: False

Has Adverse Events: True

Brief Title: Zandelisib (ME-401) in Subjects With Follicular Lymphoma or Marginal Zone Lymphoma After Failure of Two or More Prior Therapies (TIDAL)

Sponsor: MEI Pharma, Inc.

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Adverse Events Module Baseline Characteristics Module Participant Flow Module